CEBPZ and acute myeloid leukemia: KDM6A mutations were present in 8.1% of patients (6 of 74) at diagnosis with close association with CBF-rearrangements, as 30% (3 of 10) of patients with CBF-AML harbored KDM6A mutations (P = 0.0343).